Curcumin inhibited hepatitis B viral entry through NTCP binding

Hepatitis B virus (HBV) has been implicated in hepatitis and hepatocellular carcinoma. Current agents (nucleos(t)ide analogs and interferons) could only attenuate HBV infection. A combination of agents targeting different stages of viral life cycle (e.g., entry, replication, and cccDNA stability) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Thongsri, Piyanoot, Pewkliang, Yongyut, Borwornpinyo, Suparerk, Wongkajornsilp, Adisak, Hongeng, Suradej, Sa-ngiamsuntorn, Khanit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476618/
https://www.ncbi.nlm.nih.gov/pubmed/34580340
http://dx.doi.org/10.1038/s41598-021-98243-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476618/
https://www.ncbi.nlm.nih.gov/pubmed/34580340
http://dx.doi.org/10.1038/s41598-021-98243-x

Ejemplares similares